Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Ongoing Immunotherapy Challenges Part II: Defining Benefit for Elderly Patients With...
lungcanc
Dr. Chandra P. Belani Named New Chief Science Officer for the...
lungcanc
Multidisciplinary Teams at AUSL Romagna
lungcanc
Rebuilding Choice Architecture for Incurable but Treatable Lung Cancer: Rethinking the...
lungcanc
PD-L1 in Cytology Specimens
lungcanc
A Balancing Act: Managing Patients’ Expectations
lungcanc
Journal Radar: Robust Survival Duration Shown in NSCLC With Pembrolizumab
lungcanc
STARS Patient Research Advocate Training Program Seeks Patients and Caregivers
lungcanc
Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint...
lungcanc
First-Ever IASLC School of Nursing Held at Latin American Lung Cancer...
lungcanc
1
...
10
11
12
...
53
Page 11 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
